# Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

> **NCT00144664** · PHASE3 · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 19 (actual)

## Conditions studied

- Systemic Juvenile Idiopathic Arthritis

## Interventions

- **DRUG:** MRA(Tocilizumab)

## Key facts

- **NCT ID:** NCT00144664
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-04
- **Final completion:** 2005-10
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2008-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144664, "Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00144664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*